Document is current
Any future updates will be listed below
-
Authors
Courelli, Asimina S.
Sharma, Ashwyn K.
Madlensky, Lisa
Choi, Yoon Young
Li, Sam
Sarno, Shirley
Kelly, Kaitlyn
Mehtsun, Winta
Horgan, Santiago
Harismendy, Olivier
Baumgartner, Joel M.
Sicklick, Jason K.
- License Information
-
More Information
Article History
First Online: 5 September 2022
Disclosure
: Jason K. Sicklick receives research funds from Foundation Medicine Inc. and Amgen, consultant fees from Deciphera and Grand Rounds, speaker fees from Deciphera, La-Hoffman Roche, Foundation Medicine, Merck, and QED; he owns stock in Personalis. Ashwyn K. Sharma received financial support through the NIH T32 CA121938 Cancer Therapeutics (CT2) Training Fellowship. The remaining authors have no competing interests.
